Your Digital Pathology Experts
OracleBio supports Pharmaceutical R&D with detailed quantification of histopathology images, harnessing cutting-edge technology such as AI deep learning and cloud computing to transform preclinical and clinical research.
Leading the way in advanced quantitative image analysis for Pharma R&D
Latest Blogs & Insights
Utilizing AI to improve analysis accuracy and turnaround time for Preclinical tumor model IHC studies
⚡ Article Synopsis: In this article, we highlight a previous webinar case study where we utilized AI deep learning techniques to improve the accuracy and turn-around time for quantification of cytotoxic T-cell (CD8 marker), macrophage (F4/80 marker), and vasculature...
The use and value of the preclinical Bleomycin model in Drug Development for Idiopathic Pulmonary Fibrosis (IPF)
⚡ Article Synopsis: In this article, OracleBio has come together with one of our partners, TherapeutAix, who provide strategic and operational support for drug development projects, to provide our collective thoughts on the use and value of the preclinical Bleomycin...
In July 2021, the creation of OracleBio’s dedicated Research & Development group marked an important milestone in our growth strategy. In this article, we go behind the scenes and take a retrospective look at what we have achieved over the past year, and give you...
About this Webinar: Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the past few years have created unprecedented opportunities to better identify biomarkers of disease processes, especially by using...
About this Webinar: This session, 'Using Artificial Intelligence (AI) to support Quantitative Digital Pathology in R&D', was live on Wednesday 17th November 2021. You can re-watch the full webinar including the Q&A above. Presented by OracleBio's Chief...
Good clinical practice (GCP) is an internationally recognised ethical and scientific standard for designing, recording and reporting trials that involve the participation of human subjects. For quantitative image analysis data to be included in a data package...
We are a specialised CRO, with years of experience delivering high quality data for small, medium and large Pharma. Highly skilled in quantitative digital pathology, we’re able to expertly address complex image analysis studies.
Our Good Clinical Practice (GCP) service offering generates quantitative image analysis data using a workflow that is conducted in accordance with GCP principles.
This provides our clients with quality assured data which can be included in a data package for submission to regulatory authorities.
We provide high precision, quantitative digital pathology services to support pre-clinical and clinical research. Delivering accurate and detailed quantification of nuclear, membrane and cytoplasmic markers on a cell-by-cell basis within Histology, IHC and ISH tissue sections.